Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Study of Epidemiological Characteristics and In-silico Analysis of the Effect of Interventions in the SARS-CoV-2 Epidemic in India

Archisman Mazumder, Vishwesh Bharadiya, Parul Berry, Mehak Arora, Mudit Agarwal, Mohak Gupta, Giridara Gopal Parameswaran, Priyamadhaba Behera
doi: https://doi.org/10.1101/2020.04.05.20053884
Archisman Mazumder
1MBBS student, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vishwesh Bharadiya
1MBBS student, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Parul Berry
1MBBS student, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehak Arora
1MBBS student, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mudit Agarwal
2Intern, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohak Gupta
2Intern, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giridara Gopal Parameswaran
3MD, Senior Scientist, Department of Community Medicine, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Priyamadhaba Behera
4MD, Assistant Professor, Department of Community Medicine, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: priya.madhaba@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

After SARS-CoV-2 set foot in India, the Government took a number of steps to limit the spread of the disease in the country. This study involves assessing how the disease affected the population in the initial days of the epidemic. Data was collected from government-controlled and crowdsourced websites and analyzed. Studying age and sex parameters of 413 Indian COVID-19 patients, the median age of the affected individuals was found to be 36 years (IQR, 25-54) with 20-39 years males being the most affected group. The number of affected males (66.34%) was more than that of the females (33.66%). Using Susceptible-Infected-Removed (SIR) model, the range of contact rate (β) of India was calculated and the role of public health interventions was assessed. If current contact rate continues, India may have 5583 to 13785 active cases at the end of 21 days lockdown.

Article Summary Line The study gives the epidemiological characteristics of the SARS-CoV-2 epidemic in India, where unlike other countries, the 20-39 years males are most affected, and the SIR model predicts the probable number of cases of COVID-19 by the end of the 21 days lockdown in the country, which will help to develop appropriate public health interventions to control the COVID-19 epidemic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding recieved

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data taken from publicly available crowdsourced and government databases

https://www.covid19india.org/

  • ABBREVIATIONS

    IQR
    Interquartile Range
    SIR
    Susceptible-Infected-Removed
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted April 14, 2020.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Study of Epidemiological Characteristics and In-silico Analysis of the Effect of Interventions in the SARS-CoV-2 Epidemic in India
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Study of Epidemiological Characteristics and In-silico Analysis of the Effect of Interventions in the SARS-CoV-2 Epidemic in India
    Archisman Mazumder, Vishwesh Bharadiya, Parul Berry, Mehak Arora, Mudit Agarwal, Mohak Gupta, Giridara Gopal Parameswaran, Priyamadhaba Behera
    medRxiv 2020.04.05.20053884; doi: https://doi.org/10.1101/2020.04.05.20053884
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Study of Epidemiological Characteristics and In-silico Analysis of the Effect of Interventions in the SARS-CoV-2 Epidemic in India
    Archisman Mazumder, Vishwesh Bharadiya, Parul Berry, Mehak Arora, Mudit Agarwal, Mohak Gupta, Giridara Gopal Parameswaran, Priyamadhaba Behera
    medRxiv 2020.04.05.20053884; doi: https://doi.org/10.1101/2020.04.05.20053884

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (70)
    • Allergy and Immunology (168)
    • Anesthesia (51)
    • Cardiovascular Medicine (452)
    • Dentistry and Oral Medicine (83)
    • Dermatology (55)
    • Emergency Medicine (158)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
    • Epidemiology (5268)
    • Forensic Medicine (3)
    • Gastroenterology (196)
    • Genetic and Genomic Medicine (759)
    • Geriatric Medicine (80)
    • Health Economics (213)
    • Health Informatics (699)
    • Health Policy (360)
    • Health Systems and Quality Improvement (224)
    • Hematology (99)
    • HIV/AIDS (164)
    • Infectious Diseases (except HIV/AIDS) (5889)
    • Intensive Care and Critical Care Medicine (363)
    • Medical Education (105)
    • Medical Ethics (25)
    • Nephrology (83)
    • Neurology (767)
    • Nursing (43)
    • Nutrition (131)
    • Obstetrics and Gynecology (143)
    • Occupational and Environmental Health (234)
    • Oncology (480)
    • Ophthalmology (152)
    • Orthopedics (39)
    • Otolaryngology (95)
    • Pain Medicine (39)
    • Palliative Medicine (20)
    • Pathology (141)
    • Pediatrics (223)
    • Pharmacology and Therapeutics (136)
    • Primary Care Research (98)
    • Psychiatry and Clinical Psychology (864)
    • Public and Global Health (2021)
    • Radiology and Imaging (349)
    • Rehabilitation Medicine and Physical Therapy (158)
    • Respiratory Medicine (287)
    • Rheumatology (94)
    • Sexual and Reproductive Health (74)
    • Sports Medicine (77)
    • Surgery (110)
    • Toxicology (25)
    • Transplantation (29)
    • Urology (39)